Re: Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Hashim Uddin
HU
Ahmed
Mark
M
Emberton
D000726:Androgen Antagonists / Q000627:therapeutic use; D003452:Cryosurgery / Q000379:methods; D003657:Decision Making; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009367:Neoplasm Staging; D018579:Patient Selection; D010778:Photochemotherapy / Q000379:methods; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D020266:Radiotherapy, Conformal / Q000379:methods; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D016896:Treatment Outcome; D036761:Ultrasound, High-Intensity Focused, Transrectal / Q000379:methods
D000726:Androgen Antagonists; D017430:Prostate-Specific Antigen